-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Corteva, Lowers Price Target to $86

Benzinga·06/09/2026 15:31:12
Listen to the news
UBS analyst Joshua Spector maintains Corteva (NYSE:CTVA) with a Neutral and lowers the price target from $90 to $86.